.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Daiichi Sankyo
Mallinckrodt
Covington
Cerilliant
McKinsey
US Army
Chinese Patent Office
Healthtrust

Generated: September 21, 2017

DrugPatentWatch Database Preview

Propranolol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for propranolol hydrochloride and what is the scope of propranolol hydrochloride freedom to operate?

Propranolol hydrochloride
is the generic ingredient in six branded drugs marketed by Inwood Labs, Sandoz Inc, Rp Scherer, Frontida Biopharm, Duramed Pharms Barr, Pierre Fabre Derma, Upsher-smith Labs, Mylan, Northstar Hlthcare, Purepac Pharm, Superpharm, Roxane, Lederle, Vintage Pharms, Wyeth Pharms Inc, Baxter Hlthcare Corp, Schering, Zydus Pharms Usa Inc, Dava Pharms Inc, Fresenius Kabi Usa, Teva, Smith And Nephew, Solopak, Wyeth Ayerst, Ani Pharms Inc, Warner Chilcott, Watson Labs, Watson Labs Teva, Ipca Labs Ltd, Sandoz, Hikma Farmaceutica, Ivax Sub Teva Pharms, Nortec Dev Assoc, Interpharm, Impax Labs Inc, West-ward Pharms Int, Morton Grove, Par Pharm, Athenex Inc, and Actavis Elizabeth, and is included in one hundred and thirty-five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Propranolol hydrochloride has fifty-two patent family members in thirty-one countries.

There are twenty-one drug master file entries for propranolol hydrochloride. Fifty-six suppliers are listed for this compound.

Summary for Generic Name: propranolol hydrochloride

Tradenames:6
Patents:2
Applicants:40
NDAs:135
Drug Master File Entries: see list21
Suppliers / Packagers: see list56
Bulk Api Vendors: see list80
Clinical Trials: see list2,458
Patent Applications: see list4,499
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:propranolol hydrochloride at DailyMed

Pharmacology for Ingredient: propranolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
TABLET;ORAL070141-001Jul 30, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078022-001Feb 15, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Nortec Dev Assoc
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078065-003Jan 26, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
INNOPRAN XL
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021438-002Mar 12, 2003BXRXNoNo► Subscribe► SubscribeY ► Subscribe
Vintage Pharms
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
TABLET;ORAL070221-001Apr 14, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe
Pierre Fabre Derma
HEMANGEOL
propranolol hydrochloride
SOLUTION;ORAL205410-001Mar 14, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Purepac Pharm
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
TABLET;ORAL070817-001Nov 3, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL090321-003Mar 25, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
TABLET;ORAL070663-001Jun 13, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
TABLET;ORAL071327-001Oct 1, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: propranolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
INDERAL
propranolol hydrochloride
SUSPENSION;ORAL019536-001Dec 12, 1986► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-001Apr 19, 1983► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-003Apr 19, 1983► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-002Apr 19, 1983► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-004Mar 18, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: propranolol hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,987,262Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas► Subscribe
9,358,214Timed, sustained release systems for propranolol► Subscribe
9,040,086Timed, sustained release systems for propranolol► Subscribe
9,173,858Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: propranolol hydrochloride

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)03028708► Subscribe
Spain2368299► Subscribe
Slovenia2233135► Subscribe
South Korea101562627► Subscribe
Saudi Arabia2799► Subscribe
Morocco31843► Subscribe
Hong Kong1140530► Subscribe
Norway20041740► Subscribe
Tunisia2010000170► Subscribe
South Korea101090719► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cerilliant
McKesson
Moodys
Novartis
Mallinckrodt
Daiichi Sankyo
Farmers Insurance
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot